Literature DB >> 5128383

Comparative neutralization of lung- and mucosal-derived heparin by protamine sulfate using in vitro and in vivo methods.

L R Lowary, F A Smith, E Coyne, N W Dunham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5128383     DOI: 10.1002/jps.2600600436

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  Protamine and protamine-insulins exacerbate the vascular response to injury.

Authors:  E R Edelman; L A Pukac; M J Karnovsky
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 2.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

3.  A Nanoscale Tool for Photoacoustic-Based Measurements of Clotting Time and Therapeutic Drug Monitoring of Heparin.

Authors:  Junxin Wang; Fang Chen; Santiago J Arconada-Alvarez; James Hartanto; Li-Peng Yap; Ryan Park; Fang Wang; Ivetta Vorobyova; Grant Dagliyan; Peter S Conti; Jesse V Jokerst
Journal:  Nano Lett       Date:  2016-09-28       Impact factor: 11.189

Review 4.  Protamine--antagonist to heparin.

Authors:  L B Jaques
Journal:  Can Med Assoc J       Date:  1973-05-19       Impact factor: 8.262

5.  [Influence of five commercial heparin preparations on the collagen induced platelet aggregation (author's transl)].

Authors:  G Kronik; E Deutsch
Journal:  Blut       Date:  1977-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.